创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: iHuPBMC-B Mouse Model

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-09 13:45
  • Views:

(Summary description)With the further development of biomedical research, scientists have an increasing need for experimental models. In recent years, InnoModels Biotechnology has developed the iHuPBMC-B mouse model, an innovative model that has shown great potential and application value in biomedical research.

InnoModels Biotechnology: iHuPBMC-B Mouse Model

(Summary description)With the further development of biomedical research, scientists have an increasing need for experimental models. In recent years, InnoModels Biotechnology has developed the iHuPBMC-B mouse model, an innovative model that has shown great potential and application value in biomedical research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-09 13:45
  • Views:
Information

With the further development of biomedical research, scientists have an increasing need for experimental models. In recent years, InnoModels Biotechnology has developed the iHuPBMC-B mouse model, an innovative model that has shown great potential and application value in biomedical research.
The core of the iHuPBMC-B mouse model is its unique source of B lymphocytes. The model utilizes advanced cell culture and expansion techniques to efficiently obtain B lymphocytes from human Peripheral Blood Mononuclear Cells (PBMCs). This technique ensures that the resulting B lymphocytes have a high degree of activity and functional integrity, thus guaranteeing reliable and reproducible experimental results.
B lymphocytes play a crucial role in the human immune system, where they are responsible for producing antibodies against foreign pathogens. By introducing human-derived B lymphocytes into the mouse model, scientists can more accurately mimic the response of the human immune system, leading to a better understanding of the process of disease onset and progression.

 


The iHuPBMC-B mouse model has a wide range of applications and can be used in a variety of fields including in vitro experiments, drug screening, and disease modeling studies. During drug development, the model can help scientists more accurately assess the effects of drugs on the immune system, thus improving the success and efficiency of drug development. In disease modeling research, the iHuPBMC-B mouse model can simulate the occurrence and development of certain autoimmune and infectious diseases, providing new ideas and methods for disease treatment and prevention.
In addition, the iHuPBMC-B mouse model has the advantage of personalized service. Researchers can customize the personalized model according to the specific needs of the experiment, so as to better meet the experimental needs. This personalized service enables researchers to carry out experimental work more flexibly and efficiently, promoting the progress of biomedical research.
In conclusion, InnoModels' iHuPBMC-B mouse model is a revolutionary biomedical research tool. It utilizes advanced cell culture and expansion techniques to introduce human-derived B lymphocytes, providing researchers with a more accurate and reliable experimental model. This model has a wide range of applications and can be used in a variety of fields such as drug discovery and development, disease modeling research, etc., making an important contribution to the advancement of biomedical research. In the future, with the continuous development and improvement of the technology, the iHuPBMC-B mouse model is expected to show its unique advantages and value in more fields.

Keyword:

In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司